Valeant CEO to tell Senate committee drug price increases were ‘too aggressive’

Valeant CEO Pearson will testify before a Senate committee Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.